A Pasteurella haemolytica cosmid clone that activates leukotoxin transcription in Escherichia coli has been isolated. The activator locus, alxA, is part of a continuous open reading frame that includes the type I hsdM methylase gene. AlxA and HsdM peptides are processed from a precursor, and translation of the polyprotein can be modulated by slipped-strand mispairing across a pentanucleotide repeat, ACAGC, within the 5 end of alxA-hsdM. Extracts containing AlxA can bind to a leukotoxin promoter fragment.
pSH2001 is shown in Fig. 1a . The remaining transductants that produced the dark-blue phenotype had restriction patterns different from that of pSH2001. One of these appears to carry the P. haemolytica ␤-galactosidase gene since it complements a lacZ deletion in E. coli (data not shown).
By subcloning fragments of pSH2001 into plasmid pBCKS (Stratagene, La Jolla, Calif.), transforming them into strain SH370, and testing for color change on plates containing XGal, the activator was mapped to the 1.29-kb XmnI fragment of pSH2001 (Fig. 1b) . A plasmid carrying the 1.29-kb XmnI fragment in the opposite orientation of insertion, where transcription would be driven by the lac promoter, was not obtained during the subcloning process, implying that overexpression of its gene product(s) may be lethal to the cell. Plasmids encoding the activator function were so unstable in SH370 that it was difficult to reisolate the original plasmid following overnight growth in broth culture. As a result, a second, stable operon fusion strain, SH368, which carries a smaller, 274-bp HinfI fragment that includes the leukotoxin promoter, the DNA bend region, and the putative upstream activator sites (10) , was used for subsequent analyses.
The activator locus increases leukotoxin transcription in E. coli. Transcriptional activation by plasmid subclones was quantitated by measuring ␤-galactosidase activities in strain SH368, as described previously (11, 18) (Fig. 2) . Plasmid pSH2007, carrying the entire 5-kb EcoRI fragment, and plasmid pSH2026, carrying the internal 1.29-kb XmnI fragment, increased activity four-to fivefold, while pSH2021, carrying the DraIII to EcoRI fragment, did not activate transcription. This confirmed that the activator locus maps within the 1.29-kb XmnI fragment. The 1.29-kb XmnI fragment was also cloned in P. haemolytica by using the shuttle vector, pNF2176 (2), to create plasmid pVH2273. This plasmid did not enhance leukotoxin expression in P. haemolytica (data not shown), presumably because of deletions within the activator reading frame, as described below.
DNA sequence of the activator locus. The nucleotide sequence of the 5-kb EcoRI fragment and additional flanking DNA was determined (8) . A 616-codon open reading frame initiates within the 0.45-kb DraIII fragment, crosses the XmnI site at 2.9 kb, and ends before the XmnI site at 4.1 kb (Fig. 3) . This reading frame encodes two separate activities. Complementation using the 1.29-kb XmnI fragment on pSH2026 ( Fig.  1b and 2 ) indicated that activator function maps within the amino-terminal one-third of the reading frame. Sequences ho-mologous to the amino-terminal protein sequence were not found in database searches, yet the carboxy-terminal twothirds of the peptide is 74% identical to the predicted HsdM methylase subunit of the type I restriction-modification enzyme from Haemophilus influenzae (4). As we have reported, the associated specificity (hsdS) and restriction (hsdR) subunit genes map downstream of hsdM, and methylase activity is correlated with the carboxy-terminal portion of the 616-codon reading frame (8) . Thus, the activator gene, which is called alxA, for activator of leukotoxin expression, forms the first of a four-gene cluster that encodes both transcriptional activation function and the type I restriction-modification system of P. haemolytica A1.
The AlxA amino acid sequence provided few clues to its role in leukotoxin promoter activation, since no DNA binding motif was detected. The predicted peptide begins with the pentapeptide repeat TAQHS, which occurs 13 times within the amino terminus of the protein. This is encoded by 40 copies of the pentanucleotide DNA repeat, ACAGC. Addition or deletion of a single pentanucleotide repeat, by slipped-strand mispairing across the sequence (16), causes frame shifting that results in termination of activator translation at one of two UGA triplets that occur downstream of the repeats (Fig. 3) . The repeat region is followed by two sets of hydrophobic leucine heptad repeat sequences (amino acids 81 to 109 and amino acids 145 to 173). Such repeats often constitute leucine zipper domains in eukaryotic and prokaryotic transcription factors (14, 21) . In addition, an overlapping acidic region (amino acids 136 to 168), characteristic of some transcription factors (19) , was also observed in the AlxA sequence. Acidic repeats have been implicated in promoter melting by the alternate sigma factor 54 (28) . The inferred amino acid sequence of AlxA correcting a frameshift 3Ј to the repeat region, a 558-codon reading frame, with a plausible AUG start codon and appropriate ribosome binding sequence, can be restored. Excluding the repeat region, the AlxA-HsdM and H. influenzae protein sequences are 69% identical.
The structural motifs described here suggest that AlxA could interact with core RNA polymerase or other transcription factors to assist transcription initiation but that AlxA may not bind DNA alone. By analogy to the B. pertussis adenylate cyclase and pertussis toxin regulons, it is plausible that AlxA performs a function similar to that provided by the Bordetella activating factor, Baf (1) . Genetic studies suggest that Baf interacts with the RNA polymerase ␣ subunit and acts in concert with the BvgAS two-component regulatory system to activate transcription. It is proposed, then, that AlxA is a unique protein that may utilize a leucine zipper structure to effect an interaction with RNA polymerase or other proteins to enhance leukotoxin transcription.
Identification of AlxA and HsdM proteins. trans-activation indicated that the 1.29-kb XmnI fragment was sufficient for alxA function, yet the 616-codon reading frame traverses the XmnI site. In vitro transcription and translation were performed, with the Prokaryotic DNA-directed Translation Kit from Amersham (Arlington Heights, Ill.), used as recommended by the manufacturer, to determine if one or more polypeptides were produced from the alxA-hsdM genes. A large peptide of about 72 kDa and two smaller peptides of 38 and 31 kDa were produced by the EcoRI clone pSH2007 (Fig.  4) . These are consistent with proteolytic processing of a single precursor into 31-kDa AlxA and 38-kDa HsdM peptides. Further confirmation of the precursor-product relationship between the large peptide and AlxA was revealed when plasmid pSH2026 was used as a template for the in vitro transcriptiontranslation reaction. In this case, a peptide of about 33 kDa was observed (AlxA*). This is slightly larger than that produced with pSH2007, suggesting that the appropriate processing site is missing from the run-off peptide encoded by pSH2026. Plasmid pSH2007 produced more AlxA peptide than did pSH2026; this was expected, since transcription on pSH2007 can be driven by the lac promoter on the vector. Nevertheless, with pSH2007, the AlxA peptide was more abundant than the polyprotein or HsdM; the reason for this is unknown. A potential site for cleavage could occur at glutamate 283 (Fig. 3 , wavy underline) since residues preceding it (ALA ٙ EG [where ٙ is a cleavage site]) follow the (Ϫ3, Ϫ1) alanine rule for signal cleavage sites (25) . Cleavage at this site would create peptides that are 32 and 37 kDa, in close agreement with the 31-and 38-kDa peptides observed. This putative cleavage site is conserved in the analogous H. influenzae sequence, where the sequence is AQA ٙ EG. It should be noted, however, that the region preceding Glu-283 does not resemble a canonical signal sequence, and it is unlikely that it is recognized as such. Knowledge of the precise location of the cleavage site remains to be determined.
Slipped-strand mispairing within alxA. To provide evidence for slipped-strand mispairing within alxA, we first examined 11 P. haemolytica strains and 1 Pasteurella multocida strain for DNA fragment length heterogeneity within the 1.29-kb XmnI fragment. By Southern blotting, fragments varying from about 1.1 to 1.35 kb were observed in place of the 1.29-kb XmnI fragment seen in PHL101 (data not shown). Hybridizing DNA was not observed when a P. multocida strain was probed. To obtain a more precise measurement of the number of ACAGC repeats within a strain, fragments containing the repeat region were amplified from chromosomal or plasmid DNAs by PCR using primers that flank the repeat region (Fig. 3) . Approximately 1 g of target DNA was amplified with 100 pmol of each primer under standard cycle conditions (20) by using TaqI DNA polymerase (Promega, Madison, Wis.). When the strains were analyzed by polyacrylamide gel electrophoresis (Fig. 5) , a predominant species was detected for each strain, along with a ladder of bands that represented amplimers of fragments carrying 1 to about 50 repeats. A PCR product was detected with P. multocida DNA, but no ladder was observed, indicating that the amplified fragment lacks the repeats. The length of the predominant fragment in each sample ranged from those containing 16 pentanucleotide repeats (PHL195) to those containing 47 repeats (PHL211). For the plasmids, repeat length was verified by sequencing the template (data not shown). DNA sequencing revealed that the pVH2273 fragment (33 repeats) was out of frame; this may explain our failure to observe activation of leukotoxin expression in P. haemolytica when this subclone was used.
Interaction of AlxA with a leukotoxin promoter fragment. Since AlxA acts as a transcriptional activator, gel mobility shift experiments were performed to test whether the protein could interact with the leukotoxin promoter. Cleared whole-cell extracts from E. coli strains expressing alxA were used to examine the interaction of AlxA with a 274-bp HinfI promoter fragment. Extracts were prepared by sonication of mid-logarithmic-phase cells, as previously described (10) . As illustrated in Fig. 6 , in the presence of AlxA, specific DNA-protein complexes (I, II, and III) are formed. Extracts from cells carrying pSH2026 or pSH2007 yielded three shifted complexes, though the pSH2026 extract reacted weakly with the promoter fragments. A mobility shift was not observed when these extracts were used with a nonspecific probe derived from the Gibco-BRL 1-kb ladder (Fig. 6, lanes 5 to 8) . Note that the 274-bp leukotoxin promoter fragment migrates more slowly than the 298-bp fragment because of the presence of a static DNA bend within the promoter region that retards its electrophoresis (10) . The gel mobility shift data indicate that AlxA can interact with leukotoxin promoter DNA, but it has not been established if AlxA alone is a DNA-binding protein or if it interacts with other transcription factors to bind the promoter fragment. Formation of distinct bound species was observed only when diluted extracts were used; addition of larger amounts of the extract caused a supershift, and distinct shifted species were not observed (data not shown). Using whole cell extracts, one cannot conclude if the gel-shifted species result from a direct DNA-AlxA interaction or from interactions of AlxA with other DNA binding proteins, such as RNA polymerase holoenzyme.
Identification of an activator of leukotoxin transcription supports our model for leukotoxin promoter control and should aid us in isolating other trans-acting proteins involved in its transcription. In E. coli, the level of activation provided by AlxA was fivefold. This is consistent with results obtained with an lktC-chloramphenicol acetyltransferase operon fusion in P. haemolytica, with which a two-to sixfold increase in leukotoxin expression during the logarithmic growth phase was observed (3) . Modulation of alxA expression by slipped-strand mispairing could explain reported variations in leukotoxin production observed in different P. haemolytica isolates (9) . The repeats may also affect expression of the downstream hsd genes by altering the reading frame and causing premature termination of translation. Prior to this report, slipped-strand mispairing had only been identified as a mechanism for phase variation within genes that expressed surface antigens (23, 26) . Here, the mechanism is shown to modulate translation of a transcription factor involved in synthesis of a secreted virulence factor.
Nucleotide sequence accession number. The nucleotide and predicted amino acid sequences of alxA and hsdM have been assigned GenBank accession no. U46781.
